作者: AnthonyJ. Handley
DOI: 10.1016/S0140-6736(72)93016-4
关键词: Heparin 、 Medicine 、 Fibrinogen 、 Low dose heparin 、 Cardiology 、 Thrombosis 、 Internal medicine 、 Myocardial infarction 、 Subcutaneous heparin
摘要: Abstract A trial of low-dose subcutaneous heparin in the prevention deep-vein thrombosis was undertaken 50 patients with myocardial infarction. The development lower-limb detected by radioactive fibrinogen technique 23% who received and 29% controls. This difference is not significant.